Linked Life Data

17659210

Source:http://linkedlifedata.com/resource/pubmed/id/17659210

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2007-7-30
pubmed:abstractText
Over the past decade, non-fermenting Gram-negative bacteria have emerged as important opportunistic pathogens in the increasing population of patients who are immunocompromised by their disease or medical treatment. These bacteria are assisted by their ubiquitous distribution in the environment and have a propensity for multiple, intrinsic or acquired drug resistance. The infections that they cause now pose significant problems in terms of treatment and infection control, whilst the commonly observed rapid emergence of bacterial resistance to new antimicrobial compounds raises concerns regarding the clinical lifespan of these agents. Studies are urgently required to assess whether combination therapy can improve the long-term utility of new drugs in the treatment of patients infected with non-fermenters.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0924-8579
pubmed:author
pubmed:issnType
Print
pubmed:volume
29 Suppl 3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S33-41
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Non-fermentative Gram-negative bacteria.
pubmed:affiliation
Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QW, UK. david.enoch@addenbrookes.nhs.uk
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't